http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
CytoSorbents Congratulates Kathleen Bloch as NJBIZ Public Company Chief Financial Officer of the Year
-
CytoSorbents to Present at the 2016 BIO Investor Forum
-
CytoSorbents and Foxx Medical Begin Saving Lives in Chile with CytoSorb®
-
Cytosorbents (CTSO) Announces Positive Data from REFRESH I Trial; Primary Safety Endpoint Met
-
CytoSorbents Announces Positive Top-line Safety Data from REFRESH I Cardiac Surgery Trial
-
New CytoSorbents Website Highlights Global Growth and Innovation
-
CytoSorbents Expands CytoSorb® into Iran with Partner Arsak
-
CytoSorbents Sponsors Sepsis Heroes Gala in Honor of World Sepsis Day
-
CytoSorbents Advances War On Sepsis with Development of CytoSorb-XL
-
CytoSorbents Advances War On Sepsis with Development of CytoSorb-XL
-
CytoSorbents to Present at the 2016 Rodman & Renshaw Annual Global Investment Conference
-
CytoSorbents to Present at the 2016 Rodman & Renshaw Annual Global Investment Conference
-
CytoSorbents Achieves Fourth Consecutive Quarter of Record CytoSorb® Sales
-
CytoSorbents Awarded $650,000 in SBIR Grant Contracts to Continue Development of Novel Hemocompatible Potassium Binding Polymers
-
CytoSorbents to Report Q2 2016 Operating and Financial Results
-
CytoSorbents Teams with Medial and Meditrade to Bring CytoSorb® to Hungary, Czech Republic, Slovakia, and Poland
-
CytoSorbents to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
CytoSorbents Closes $10 Million Debt Financing with Bridge Bank
-
CytoSorbents Awarded $150,000 Phase I STTR Contract for Universal Plasma Development
-
CytoSorbents and Palex Bring CytoSorb® to Spain and Portugal
-
Independent Data Safety Monitoring Board Recommends Continuation of CytoSorbents REFRESH I Trial
-
CytoSorb® Achieves Final Product Registration in Russia
-
CytoSorbents Continues Strong Growth in Q1 2016
-
CytoSorbents Establishes Swiss Subsidiary
-
CytoSorbents to Report Q1 2016 Operating and Financial Results
-
CytoSorbents To Present At The 15th Annual Needham Healthcare Conference
-
CytoSorbents Awarded $150,000 Phase I SBIR Contract for Fungal Mycotoxin Removal
-
CytoSorbents to Host 3rd International CytoSorb® Users Meeting and ISICEM 2016 Symposium
-
CytoSorbents Reports Record Quarterly and Full-Year 2015 Revenue
-
CytoSorbents to Report Fiscal 2015 Operating and Financial Results
-
Data Presented on First CytoSorb® Investigator-Initiated Septic Shock Study
-
CytoSorbents to Exhibit at the 45th Society of Critical Care Medicine Congress
-
CytoSorbents Announces 26th Symposium for Intensive Medicine and Intensive Care Agenda in Bremen, Germany
-
CytoSorbents to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference
-
CytoSorbents Receives $325,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program
-
CytoSorbents to Present at the 18th Annual BIO CEO & Investor Conference
-
CytoSorbents Appoints Dr. Volker Humbert as Senior Manager of Clinical Affairs
-
CytoSorbents 2016 - Driving Toward the Inflection Point
-
CytoSorbents To Present at Biotech Showcase 2016
-
CytoSorbents Corporation (Nasdaq:CTSO) to Ring The Nasdaq Stock Market Opening Bell
-
CytoSorbents Issues EAP Update
-
CytoSorbents Expands Distribution of CytoSorb® to Vietnam
-
CytoSorbents to Ring Opening Bell to Celebrate One Year NASDAQ Anniversary
-
CytoSorbents Accelerates Growth in Q3 2015
-
CytoSorbents To Meet With Investors at Brean Capital Life Sciences Summit and Stifel 2015 Healthcare Conference
-
CytoSorbents to Report Q3 2015 Operating and Financial Results
-
CytoSorbents To Advance HemoDefend™ Towards Commercialization with $1.5 Million Phase II SBIR Contract from NHLBI/NIH
-
CytoSorbents Reports CytoSorb® Usage Grows to 8,000+ Human Treatments at Successful Second International Users Meeting
-
CytoSorbents Ready for Second International CytoSorb® Users Meeting, ESICM and EACTS Conferences
-
World Sepsis Day 2015: CytoSorbents Sponsors the SepsisUpdate 2015 Congress, Hugo Schottmuller Prize, and Sepsis Heroes Ceremony

